James L. Tyree, Executive Vice President at ABBOTT LABORATORIES (ABT), sold 17,267 shares at $47.68 ($843K) on 2009-02-27, disclosed to the SEC on 2009-03-03.
Scheduled sale ($843k) by Executive Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $47.67 | 5,554 | $265K | 31.4% |
| 2 | $47.68 | 200 | $10K | 1.1% |
| 3 | $47.68 | 1,300 | $62K | 7.4% |
| 4 | $47.69 | 200 | $10K | 1.1% |
| 5 | $47.69 | 1,500 | $72K | 8.5% |
| 6 | $47.70 | 300 |
| $14K |
| 1.7% |
| 7 | $47.70 | 200 | $10K | 1.1% |
| 8 | $47.71 | 700 | $33K | 4.0% |
| 9 | $47.72 | 500 | $24K | 2.8% |
| 10 | $50.58 | 6,813 | $345K | 40.9% |
| Total | $48.82 avg | 17,267 | $843K | 100% |
| Filing → |
| ASRT | SELL | 2024-03-15 | $11K | — | Filing → |
| GNLX | SELL | 2023-12-14 | $192K | — | Filing → |
| ASRT | SELL | 2023-05-05 | $259K | — | Filing → |